Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

NCT02191475 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Abdominal Infection

Interventions

DRUG: glycopeptide plus carbapenem
DRUG: Haizheng Li Xing ® plus tazocin ®

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]